Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Queensland Health
Deloitte
Cantor Fitzgerald
US Department of Justice
Farmers Insurance
Federal Trade Commission
Express Scripts
Merck

Generated: November 16, 2018

DrugPatentWatch Database Preview

Captopril; hydrochlorothiazide - Generic Drug Details

« Back to Dashboard

What are the generic sources for captopril; hydrochlorothiazide and what is the scope of captopril; hydrochlorothiazide patent protection?

Captopril; hydrochlorothiazide is the generic ingredient in five branded drugs marketed by Apothecon, G And W Labs Inc, Ivax Sub Teva Pharms, Mylan, Vintage Pharms Llc, and Watson Labs, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for captopril; hydrochlorothiazide. One supplier is listed for this compound. There is one tentative approval for this compound.

Pharmacology for captopril; hydrochlorothiazide
Tentative approvals for CAPTOPRIL; HYDROCHLOROTHIAZIDE
Applicant Application No. Strength Dosage Form
➤ Sign Up➤ Sign Up50MG;25MGTABLET;ORAL

US Patents and Regulatory Information for captopril; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 074896-001 Dec 29, 1997 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
G And W Labs Inc CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 074827-003 Dec 29, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vintage Pharms Llc CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 074788-001 Dec 29, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apothecon CAPOZIDE 50/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-004 Oct 12, 1984 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 074832-001 Dec 29, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ivax Sub Teva Pharms CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 075055-004 Jun 18, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan CAPTOPRIL AND HYDROCHLOROTHIAZIDE captopril; hydrochlorothiazide TABLET;ORAL 074896-002 Dec 29, 1997 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for captopril; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apothecon CAPOZIDE 50/25 captopril; hydrochlorothiazide TABLET;ORAL 018709-003 Oct 12, 1984 ➤ Sign Up ➤ Sign Up
Apothecon CAPOZIDE 25/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-001 Oct 12, 1984 ➤ Sign Up ➤ Sign Up
Apothecon CAPOZIDE 25/25 captopril; hydrochlorothiazide TABLET;ORAL 018709-002 Oct 12, 1984 ➤ Sign Up ➤ Sign Up
Apothecon CAPOZIDE 50/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-004 Oct 12, 1984 ➤ Sign Up ➤ Sign Up
Apothecon CAPOZIDE 25/25 captopril; hydrochlorothiazide TABLET;ORAL 018709-002 Oct 12, 1984 ➤ Sign Up ➤ Sign Up
Apothecon CAPOZIDE 50/25 captopril; hydrochlorothiazide TABLET;ORAL 018709-003 Oct 12, 1984 ➤ Sign Up ➤ Sign Up
Apothecon CAPOZIDE 25/15 captopril; hydrochlorothiazide TABLET;ORAL 018709-001 Oct 12, 1984 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Queensland Health
Deloitte
Cantor Fitzgerald
US Department of Justice
Farmers Insurance
Federal Trade Commission
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.